With shares of Corning (NYSE:GLW) trading around $17, is GLW an OUTPERFORM, WAIT AND SEE, or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework.
T = Trends for a Stock’s MovementCorning produces and sells specialty glasses, ceramics, and related materials worldwide. It operates in five segments: Display Technologies, Telecommunications, Environmental Technologies, Specialty Materials, and Life Sciences. Corning has launched Corning Lotus Glass, an environmentally friendly display glass for organic LED and LCD displays that are used in portable devices such as smartphones, tablets, and notebook computers. Smart phones, tablets, notebook computers, and their related materials are seeing explosive growth in developed and developing countries around the world.
Corning on Tuesday announced its results for the fourth quarter and full year of 2013.�Core earnings per share were 29 cents, an increase of 4 percent over last year�� fourth quarter and better than expected. GAAP earnings per share were 30 cents.�Core sales were $2 billion, a 2 percent decline from the comparable period last year.��013 was a very successful year for Corning,��Wendell P. Weeks, chairman, chief executive officer, and president, said in the earnings report. ��e achieved the company�� primary performance goal of restoring earnings growth. This was accomplished by regaining positive momentum in our LCD business and growing the earnings in our other segments. We also delivered on our commitment to enhance shareholder value by increasing the cash dividend and executing more than $1.5 billion in share repurchases. The company�� performance was recognized by a 41% improvement in the year�� share price, a result with which we are delighted.��/p>
5 Best Canadian Stocks To Invest In Right Now: Niska Gas Storage Partners LLC (NKA)
Niska Gas Storage Partners LLC owns and operates natural gas storage assets in North America. It owns or contracts for approximately 185.5 billion cubic feet of total gas storage capacity. The company owns and operates gas storage facilities in Alberta, Canada, as well as in northern California and Oklahoma, the United States. Its gas storage customers include financial institutions, producers, marketers, power generators, pipelines, and municipalities. The company was founded in 2006 and is headquartered in Houston, Texas.
Advisors' Opinion:- [By Seth Jayson]
Niska Gas Storage Partners (NYSE: NKA ) is expected to report Q1 earnings on Aug. 1. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Niska Gas Storage Partners's revenues will contract -1908.0% and EPS will contract -9.5%. - [By Jake L'Ecuyer]
Leading and Lagging Sectors
In trading on Friday, energy shares were relative leaders, up on the day by about 0.06 percent. Among the leading sector stocks, gains came from Equal Energy (NYSE: EQU) and Niska Gas Storage Partners LLC (NYSE: NKA). Financial sector was the leading decliner in the US market today.
Top 5 Life Sciences Companies To Invest In 2014: Body Central Corp.(BODY)
Body Central Corp. operates as a specialty retailer of young women's apparel and accessories in the south, mid-Atlantic, and midwest regions of the United States. The company operates specialty apparel stores under the Body Central and Body Shop banners, as well as a direct business of its Body Central catalog and e-commerce Website at bodyc.com. Its stores feature an assortment of tops, dresses, bottoms, jewelry, accessories, and shoes under Body Central and Lipstick labels. As of March 8, 2012 it operated 241 specialty apparel stores in 24 states. The company, formerly known as Body Central Acquisition Corp., was founded in 1972 and is headquartered in Jacksonville, Florida.
Advisors' Opinion:- [By John Udovich]
As we approach Black Friday, small cap apparel retail stocks�Body Central Corp (NASDAQ: BODY), Abercrombie & Fitch Co. (NYSE: ANF) and Francesca's Holdings Corp (NASDAQ: FRAN) have the dubious distinction of being the sector�� worst performing stocks (according to Finviz.com) as they are down 62.8%, 29.5% and 26.4%, respectively, since the start of the year (see my previous article: This Year�� Best Performing Small Cap Apparel Retail Stocks? CACH, SMRT, PSUN & DXLG). With that performance in mind, what�sort of performance should�investors and traders alike expect from these apparel retail dogs as we head into Black Friday and the all important holiday season? Here is what you need to be aware of:
- [By Roberto Pedone]
Body Central (BODY) operates apparel stores and also conducts direct business via catalogues and Web site. This stock closed up 3.8% to $3.52 in Tuesday's trading session.
Tuesday's Range: $3.40-$3.55
52-Week Range: $3.09-$13.39
Tuesday's Volume: 475,000
Three-Month Average Volume: 421,188From a technical perspective, BODY trended higher here right above some near-term support at $3.21 with above-average volume. This move pushed shares of BODY into breakout territory, since the stock took out some near-term overhead resistance at $3.50. This move is also coming off oversold territory, since BODY's current relative strength index reading is 29.89. Oversold can always get more oversold, but it's also an area where a stock can experience a powerful bounce from.
Traders should now look for long-biased trades in BODY as long as it's trending above some key near-term support levels at $3.21 or at $3.09 and then once it sustains a move or close above Tuesday's high of $3.55 with volume that hits near or above 421,188 shares. If we get that move soon, then BODY will set up to re-test or possibly take out its next major overhead resistance levels at $4 to $4.50.
- [By Lee Jackson]
Body Central Corp. (NASDAQ: BODY) also comes in with an off-the-charts IRR of 26%. The company reported a dreadful second quarter, which hammered the share price. Body Central operates as a specialty retailer of young women’s apparel and accessories in the South, Mid-Atlantic and Midwest regions of the United States. It operates stores under the Body Central and Body Shop banners, as well as a direct business comprising its Body Central catalog and e-commerce website at bodycentral.com. The company’s stores sell tops, dresses, bottoms, jewelry, accessories and shoes, primarily under its Body Central and Lipstick labels. The lower the share price goes, the more attractive the stock becomes. The consensus price target is $11, with the high target at $12. The stock closed Thursday at $6.43.
Top 5 Life Sciences Companies To Invest In 2014: Ishares Nasdaq Biotechnology (IBB)
iShares Nasdaq Biotechnology Index Fund (the Fund) seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index consists of securities of NASDAQ-listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, and which also meet other eligibility criteria. The Index is one of the eight sub-indices of the NASDAQ Composite, which measures all common stocks listed on The NASDAQ Stock Market, Inc.
The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. The Fund�� investment advisor is Barclays Global Fund Advisors.
Advisors' Opinion:- [By John Udovich]
Yesterday, small cap�biotech Idera Pharmaceuticals Inc (NASDAQ: IDRA) surged 21.89% apparently on news about open enrollment for a clinical trial in what amounts to an orphan drug treatment, meaning its probably worth taking a closer look at the stock as well as consider its performance verses that of biotech ETFs like the iShares NASDAQ Biotechnology Index ETF (NASDAQ: IBB) and SPDR S&P Biotech ETF (NYSEARCA: XBI).
- [By John Udovich]
Yesterday, small cap biopharmaceutical stock Neurocrine Biosciences, Inc (NASDAQ: NBIX) surged 89.69% after announcing positive results for its VMAT2 inhibitor NBI-98854 as a treatment for tardive dyskinesia, meaning investors late to the party or those already in should take a closer look at the stock along with its performance verses that of biotech ETFs like the iShares NASDAQ Biotechnology Index ETF (NASDAQ: IBB) and SPDR S&P Biotech ETF (NYSEARCA: XBI).
- [By George Budwell]
Health-care stocks have had a good year, with the iShares�NASDAQ Biotechnology Index (NASDAQ: IBB ) rising more than 59% year to date. With that in mind, here's a Fool's look at three stocks that led the sector last week.�
Top 5 Life Sciences Companies To Invest In 2014: Insmed Inc.(INSM)
Insmed Incorporated, a biopharmaceutical company, focuses on the development of inhaled pharmaceuticals for the site-specific treatment of serious lung diseases. The company primarily focuses on the development of inhaled antibiotic therapy delivered via proprietary advanced pulmonary liposome technology in areas of high unmet need in lung diseases. Its lead product candidate includes ARIKACE, an inhaled antibiotic supported by positive phase 2 results for treating serious lung infections due to susceptible bacteria. The U.S. Food and Drug Administration has cleared the company's investigational new drug application to conduct a pivotal Phase 3 clinical trial of ARIKACE in nontuberculous mycobacteria lung infections. Insmed Incorporated was founded in 1999 and is based in Monmouth Junction, New Jersey.
Advisors' Opinion:- [By Garrett Cook]
Insmed (NASDAQ: INSM) shares shot up 40.31 percent to $17.49 after the company announced that the FDA granted Arikayce breakthrough therapy designation.
No comments:
Post a Comment